WITHIN 6 MONTHS FROM COVID-19 BNT162B2 VACCINE PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNF alpha HAVE SIGNIFICANTLY LOWER SEROLOGIC RESPONSES
Gastroenterology
; 162(7):S597-S597, 2022.
Article
in English
| Web of Science | ID: covidwho-1995314
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Topics:
Vaccines
Language:
English
Journal:
Gastroenterology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS